LHDXQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LHDXQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Lucira Health's PE Ratio without NRI is 0.00. Lucira Health's 5-Year EBITDA growth rate is 0.00%. Therefore, Lucira Health's PEG Ratio for today is N/A.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Lucira Health's PEG Ratio or its related term are showing as below:
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
The historical data trend for Lucira Health's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lucira Health Annual Data | |||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | |||||
PEG Ratio | - | - | - | - |
Lucira Health Quarterly Data | ||||||||||||||
Dec18 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | |
PEG Ratio | Get a 7-Day Free Trial | - | - | - | - | - |
For the Medical Devices subindustry, Lucira Health's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Lucira Health's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Lucira Health's PEG Ratio falls into.
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.
Lucira Health's PEG Ratio for today is calculated as
PEG Ratio | = | PE Ratio without NRI | / | 5-Year EBITDA Growth Rate* |
= | / | 0.00 | ||
= | N/A |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Lucira Health (OTCPK:LHDXQ) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Thank you for viewing the detailed overview of Lucira Health's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Anthony Joseph Allen | officer: Chief Operations Officer | 1412 62ND STREET, EMERYVILLE CA 94608 |
Epq Llc, Lcovd Safe Ps | other: Less than 10% owner | 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
Chad Boeding | other: CEO of 10% owner | ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111 |
Epiq Capital Group, Llc | 10 percent owner | ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111 |
Epq Llc, Lcovd Ps | 10 percent owner | 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
Epq Llc, Lflu Ps | other: Less than 10% owner | 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
Epq Llc, Ltest Ps | other: Less than 10% Owner | 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521 |
Richard Clavano Narido | officer: Interim CFO | 12 HANSEN CT, MORAGA CA 94556 |
Ghazi Kashmolah | officer: Ex. VP &Chief Quality Officer | 1412 62ND STREET, EMERYVILLE CA 94608 |
Kevin Walter Collins | officer: Chief Revenue Officer | C/O LUCIRA HEALTH, INC., 1412 62ND STREET, EMERYVILLE CA 94608 |
Dan George | officer: CFO and Treasurer | 1412 62ND STREET, EMERYVILLE CA 94608 |
Erik T. Engelson | director, officer: President and Chief Executive | 1412 62ND STREET, EMERYVILLE CA 94608 |
Debkishore Mitra | director, officer: Chief Technology Officer | 1412 62ND STREET, EMERYVILLE CA 94608 |
Tamanna Prashar | officer: Vice President | 1412 62ND STREET, EMERYVILLE CA 94608 |
Alison Mccauley | director | C/O LUCIRA HEALTH, INC., 1412 62ND STREET, EMERYVILLE CA 94608 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 05-04-2022
By PurpleRose PurpleRose • 08-02-2022
By GuruFocusNews GuruFocusNews • 06-08-2022
By Stock market mentor Stock market mentor • 01-04-2023
By Value_Insider Value_Insider • 11-01-2022
By GuruFocusNews GuruFocusNews • 05-19-2022
By GlobeNewswire GlobeNewswire • 02-22-2023
By GuruFocusNews GuruFocusNews • 05-22-2022
By GuruFocusNews GuruFocusNews • 05-29-2022
By PurpleRose PurpleRose • 08-23-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.